Abstract
Renal diseases impose considerable health and economic burdens on health systems worldwide, and there is a lack of efficient methods for the prevention and treatment due to their complexity and heterogeneity. Kidneys are organs with a high demand for energy produced by mitochondria, in which Rrm2b has critical functions as reported. The Rrm2b kidney-specific knockout mice we generated exhibited age-dependent exacerbated features, including mitochondrial dysfunction and increased oxidative stress; additionally, resulted in severe disruption of mitochondria-related metabolism. Rrm2b is vital not only to supply dNTPs for DNA replication and repair, but also to maintain structural integrity and metabolic homeostasis in mitochondria. Thence, Rrm2b deletion might induce chronic kidney defects in mice. This model can facilitate exploration of novel mechanisms and targeted therapies in the kidney diseases and has important translational and clinical implications.
Similar content being viewed by others
Introduction
Ribonucleotide reductase (an α2β2 tetramer composed of two non-identical subunits) catalyzes the rate-limiting step in the de novo reduction of ribonucleoside diphosphates to deoxyribonucleotide triphosphates (dNTPs) during DNA synthesis and repair in the nucleus and mitochondria. Ribonucleotide reductase M2B (Rrm2b), also known as p53R2, is a subunit of the ribonucleotide reductase complex. Rrm2b is a p53-inducible gene that was first identified in cancer-derived human cells with a highly regulated p53 expression system1,2,3. Rrm2b plays critical roles in DNA repair, mitochondrial DNA (mtDNA) synthesis, oxidative stress resistance, cell cycle regulation and metastasis suppression3,4,5,6,7,8. Kimura and colleagues generated Rrm2b-deficient mice, which developed normally until weaning and then showed growth retardation and early mortality9. Severe renal failure, caused by activation of p53-dependent apoptosis, was found in Rrm2b-deficient mice. Thence, Rrm2b seems to have critical function in kidney, but its mechanism is unclear. Rrm2b can resist oxidative stress by scavenging reactive oxygen species (ROS) and is involved in the control of mitochondria homeostasis, including structural integrity and functional capacity6,10,11,12,13. In Rrm2b knockout mouse embryonic fibroblasts (MEFs), dNTP pools were severely attenuated under oxidative stress conditions. Rrm2b deficiency also causes severe mtDNA deletion in various tissues in mice4. Recent studies have unveiled that cooperation between RRM2B and ∆1-pyrroline-5-carboxylate reductases 1 and 2 (PYCRs) can directly or indirectly modulate antioxidative responses in human telomerase reverse transcriptase (hTERT)-immortalized normal human foreskin fibroblasts (HFFs-hTERT)14. Compromised DNA repair in the nucleus and mitochondria can result in profound DNA damage and affect mitochondrial homeostasis, which can subsequently increase oxidative stress and cellular damage. Rrm2b plays an important role in DNA repair and maintenance of mitochondrial functions. In this study, we generated a mouse model with conditional knockout of Rrm2b in the renal tubular epithelium to study the effects of Rrm2b deletion on mitochondria-related and renal functions. We propose that Rrm2b deletion damages mitochondrial integrity and impedes the mitochondrial functions, resulting in the disruption of the homeostasis of mitochondrial metabolisms.
Materials and Methods
Animals
An Rrm2b targeting vector containing two direct repeats of LoxP sites that flanked exon 3 to exon 5 of the Rrm2b gene was used as a set of homologous recombination arms to create an Rrm2b floxed allele (Rrm2b Flx/Flx; Rrm2b F/F). The targeted ES cell clones (C57BL/6 strain background) were screened by Southern blot analysis using designed probes. In Cdh16-Cre transgenic mice purchased from the Jackson Laboratory (JAX 012237)15, the Cdh-16 (also known as Ksp-cadherin) promoter was activated in the tubular epithelial cells of the kidney16. Ksp-cadherin was found to be expressed in the basolateral membrane of renal tubular epithelial cells and collecting duct cells, but not in glomeruli, blood vessels, or renal interstitial cells. After two generations of breeding with the Rrm2b F/F mice, kidney-specific Rrm2b KO mice were obtained and verified using regular PCR genotyping. The mice were bred and maintained in a specific pathogen-free facility. Euthanasia was performed using CO2 inhalation. The animal protocol was approved by the Institutional Animal Care and User Committee of National Defense Medical Center and all methods were performed in accordance with the relevant guidelines and regulations.
RNA analysis
Total RNA was isolated from the kidney cortex using TRIzol Reagent (Life Technology). We performed real-time quantitative PCR using a TaqMan probe with TaqMan® Fast Universal PCR Master Mix and a real-time PCR instrument (Roche Life Science; Thermo-Fisher Scientific). Amplification was executed in triplicates for each RNA sample and primer set.
Protein and metabolite analysis
Tissue samples were homogenized in lysis buffer with complete protease inhibitor and phosphatase inhibitor cocktails (Roche) and then denatured in SDS sample buffer in a boiling water bath. The total extracted proteins were separated on an SDS–polyacrylamide gel (Bio-Rad) and transferred to a Hybond N+ membrane (GE Healthcare). The membranes were blocked with 5% (w/v) nonfat dry milk, incubated with primary antibodies against Rrm2b (1:2000, GTX109620, GeneTex) and Hsp70 (1:5000, GTX111088, GeneTex) and washed, and the proteins were detected using a Visualizer Kit (Millipore). Free glycerol in the serum and urine were measured calorimetrically using commercially available kits (Randox Lab Ltd.).
Histopathology
Tissues were fixed in formalin buffered with phosphate and embedded in paraffin. Tissue sections (4 µm) were subjected to hematoxylin-eosin (H&E), immunohistochemistry (IHC) and special staining following standard procedures17. The IHC staining was performed by incubating sections with primary antibodies, including antibodies targeting Rrm2b (1:200, PAB12860, Abnova), 4-Hydroxynonenal (4-HNE) (1:100, ab46545, abcam), and ki67 (1:50, 550609, BD Pharmingen), for 18–24 h at 4 °C, and detection was performed using biotinylated secondary antibodies and an LSAB Kit (DakoCytomation). The specific staining for kidney sections was performed using a Gomori trichrome staining kit (Polysciences, Inc.) and Picosirius red staining kit (Atom Scientific).
Transmission electron microscopy (TEM)
Mouse tissues were fixed in cacodylate buffer with glutaraldehyde (1.5%) and paraformaldehyde (1.5%), post-fixed in 1% OsO4 and rinsed in cacodylate buffer. Following dehydration, tissues were embedded in Epon and sectioned for TEM. The tissue ultrastructure was observed using a transmission electron microscope (TEM HT7700, HITACHI, Tokyo, Japan).
Mitochondria analysis
Oxygen consumption rate (OCR) of isolated mitochondria from tissues (kidney cortex) were measured using a Seahorse XFe Extracellular Flux Analyzer (Seahorse bioscience), and the results were normalized according to the protein contents of each sample. Mitochondria isolation from tissues was performed as previously described18. Mitochondrial genomic DNA was co-purified with nuclear genomic DNA, and quantitative real-time PCR was performed for detection of mt-Co2 (Cytochrome c oxidase subunit 2; mitochondrial DNA-encoded) and 18S rRNA (18S ribosomal RNA; nuclear DNA-encoded). The relative mtDNA copy number was calculated via normalization to 18S rRNA gene expression (mtDNA/nDNA)19,20.
Extraction of metabolites
Sample preparation and metabolite quantification were performed according to methods described previously21,22,23,24. Briefly, the frozen tissue (50 ~ 100 mg) was homogenized on ice in a 500-µL mixture of chloroform, methanol and water (1:2:1, v/v/v) and centrifuged at 13,000 rpm for 10 min at 4 °C, and 150 µL of the supernatant was subsequently transferred to a sample vial. The remaining pellet was rehomogenized in 500 µL of methanol, followed by a second centrifugation. Another 150 µL aliquot of supernatant was added to the same sample vial, and then, the sample was dried. The dried extract was then derivatized with 80 µL of methoxyamine (15 mg/mL in pyridine) at 30 °C for 90 min. A 10-µL aliquot of retention index compound mixture (mixture of C10-C40, 50 µg/mL) was added to the derivatized sample. The second step of the derivatization was performed by adding 80 µL of N-O-bis-(trimethylsilyl)-trifluoroacetamide (BSTFA) (1% trimethylchlorosilane) and incubating the sample at 70 °C for 120 min. The samples were subjected to gas chromatography-time of flight mass spectrometry (GC-TOF-MS) analysis directly after derivatization.
GC-TOF-MS standards
Mammalian metabolite standards were obtained from Sigma-Aldrich (St. Louis, MO), Santa Cruz Biotech. (Dallas, TX) or Avanti polar lipids (Alabaster, AL). The standards (approximately 1,000) were prepared in appropriate solutions and analyzed by GC-TOFMS to establish an in-house metabolite database.
GC-TOFMS analysis
The separation analysis was performed using an Agilent 7890N gas chromatograph in splitless mode connected to a time-of-flight mass spectrometer (LECO Corp., St. Joseph, MI). Separation was achieved using an Rxi-5ms capillary column (Crossbond® 5% diphenyl/95% dimethyl polysiloxane; Restek), with helium as the carrier gas at a constant flow rate of 1.0 mL/min. The GC oven temperature program was as follows: 2 min at 80 °C, raised by 10 °C/min to 140 °C, by 4 °C/min to 180 °C, by 10 °C/min to 240 °C and by 25 °C/min to 290 °C, followed by hold for 4.5 min at 290 °C. The temperatures of the injection, transfer interface, and ion source were set to 270, 270, and 220 °C, respectively. Mass spectra were obtained with electron impact ionization (70 eV) at full scan mode (m/z 30–600) and an acquisition rate of 25 spectra/s.
Analysis of mass spectra
Data acquisition was performed using ChromaTOF software (v4.22, LECO Corp., St. Joseph, MI). MATLAB (v7.0, Mathworks, Natick, MA) software was used to perform data pretreatment procedures, such as baseline correction, de-noising, smoothing, alignment, time-window splitting, and multivariate curve resolution25. Internal standards and any known artificial peaks, such as peaks caused by noise, column bleed and the BSTFA derivatization procedure, were removed from the data set. Metabolites were annotated through comparison with the reference standards in our in-house library. Commercially available mass spectral databases, such as the NIST library 2010 and the LECO/Fiehn Metabolomics Library, were also used for additional compound annotation (with a similarity threshed of 70%). The mass spectral data were subjected to log2 transformation and normalized by autoscaling.
Statistical analysis
All results are presented as the mean ± SD of at least three independent samples. Comparisons between two groups were calculated using Student’s t test. Statistical differences between two groups were analyzed, and the differences were considered significant when p < 0.05.
Results
Generation and characteristics of the Rrm2b kidney-specific knockout mouse model
The tubular cells of the renal cortex are rich in mitochondria, for the purpose of energy production and maintenance of tubular functions. To study the involvement of Rrm2b in renal functions, we generated renal tubular epithelial cell-specific Rrm2b knockout mice (Rrm2bflx/flx; Cdh16-Cre/+, abbreviated to Rrm2b kiKO) (Fig. 1a,b). Western blot analysis, quantitative real-time PCR and IHC staining demonstrated that Rrm2b was abundantly expressed in normal renal tubular cells and was mostly absent in Rrm2b kiKO mice (Fig. 1c–e). Rrm2b kiKO male mice exhibited significant growth retardation from ages 1 to 6 months (Fig. 1f), without a decrease in the daily intake of food and water (Fig. 1g). Serum biochemical indices were monitored and showed no obvious differences between Rrm2b kiKO mice and control Rrm2bflx/flx (F/F) mice at 3 and 6 months of age (Supplemental Fig. S1a–f). Urinary biochemical data also showed no apparent changes, except for a decrease in the pH value (Rrm2b kiKO, pH = 5.81 vs. Rrm2b F/F, pH = 6.25, p = 0.026) and a slight increase in the ketone concentration in 6-month-old kiKO mice compared with that in Rrm2b F/F mice. (Table 1). However, after fasting, Rrm2b deleted mice showed slightly lower serum insulin levels but not significant. Additionally, there were no significant differences in the blood glucose and fasting blood glucose levels between Rrm2b deleted model and control mice (Supplemental Fig. S1g–i). Pale and smaller kidneys were found in Rrm2b kiKO mice (Fig. 1h). Tubule dilation and degeneration and damage-induced inflammation were observed in the renal cortex of Rrm2b kiKO mice (Figs 1i, S2a,b). A clear sign of inflammation was also observed in female mice with Rrm2b deletion (Supplemental Fig. S2c). A marginal accumulation of collagen was also observed in the kidneys of Rrm2b kiKO mice (Fig. 1j). Additionally, sirius red sections were viewed with polarization contrast illumination suggesting the collagen accretion was dominant in Rrm2b kiKO kidney (Fig. 1k). The defects observed in the kidneys are most likely the results of the Rrm2b deficiency causing an age-dependent deterioration in kidney function. Rrm2b has also been shown to be involved in decreasing ROS activity to reduce oxidative stress. Our data showed that Rrm2b deletion resulted in enhanced expression of ROS-associated genes, such as transformation related protein 53 (Trp53) and apurinic/apyrimidinic endonuclease 1 (Apex1/Ref1) (Fig. 2a), and reduced the expression of antioxidants, such as catalase (Cat) and superoxide dismutase 1 (Sod1) (Fig. 2b), in Rrm2b kiKO kidneys relative to control Rrm2b F/F kidneys. The oxidative stress marker 4-HNE, a by-product of lipid peroxidation, was found to have significantly increased expression levels in Rrm2b knockout renal tissue (Fig. 2c). Interestingly, Pycr1 expression was dramatically increased in Rrm2b kiKO mice, and a slight increase in nuclear factor erythroid derived 2 like 2 (Nef2l2 or Nrf2) was also observed (Fig. 2d). We also found induced expression of genes associated with cell proliferation, such as cadherin 1 (Cdh1) and proliferating cell nuclear antigen (Pcna) (Fig. 2e), in Rrm2b kiKO mice, and increased cell proliferation was confirmed with IHC staining for ki67 (Fig. 2f). Therefore, Rrm2b deficiency not only promotes ROS accumulation but also weakens cellular antioxidant capacity.
Rrm2b deletion induces defects in mitochondrial functions
The mitochondria in the proximal renal tubular cells of the wild-type kidneys showed typical basal striping characteristics (Fig. 3a). In Rrm2b kiKO mice, fragmented and degenerated mitochondria were found in proximal renal tubular cells (Fig. 3a), although the genes related to mitochondrial fusion and fission showed no obvious expression level differences between Rrm2b kiKO and F/F mice (Supplemental Fig. S3a–c). These data indicate that Rrm2b deletion caused mitochondrial breakdown that was not due to the effects of mitochondrial fusion and fission. Maintenance of renal function is highly dependent on mitochondrial energy production. We found that Rrm2b deletion resulted in a decrease in oxygen consumption (Fig. 3b), which can greatly impede energy production in mitochondria. Additionally, the number of mitochondria was reduced significantly in Rrm2b knockout kidney tissue (Fig. 3c). These data provide evidence supporting the notion that Rrm2b plays a vital role in mitochondrial homeostasis.
Defects in mitochondria-involved metabolism in Rrm2b kiKO mice
To systematically understand the effects of Rrm2b-deletion in the kidney, we performed metabolic profiling analysis of the kidneys of Rrm2b kiKO and F/F mice. GC-TOF-MS analysis identified a total of 126 metabolites; of these, 13 metabolites exhibited lower concentrations and 14 exhibited higher concentrations in Rrm2b kiKO mice than in control mice (Table 2; Supplemental Table S1). In the Rrm2b kiKO kidneys, the level of glucose 6-phosphate, which is an important intermediate of the glycolysis and pentose phosphate pathways, was increased (2.6-fold) compared with that in control kidneys, and the levels of glycerol 3-phosphate and glycerol concentrations were also increased (1.27- and 1.88-fold, respectively) compared with those in control kidneys, possibly through glyceroneogenesis. When the metabolites of methionine and cysteine metabolism were examined, homocysteine, homoserine and serine concentrations were found to be lower (0.84-, 0.52- and 0.77-fold, respectively) and dimethylglycine was higher (1.27-fold) in Rrm2b kiKO mice than in control mice. Two key substrates of the citrate cycle (TCA cycle), oxoglutaric acid and succinic acid, were also found at lower concentrations (0.74- and 0.78-fold, respectively) in Rrm2b deleted kidneys relative to control (F/F) kidneys. Lastly, the caffeine metabolite 7-methylxanthine was found at higher concentrations (1.72-fold) in Rrm2b kiKO mice than in control mice (Supplemental Table S1).
Altered expression of key metabolic genes in Rrm2b kiKO mice
Rrm2b deficiency led to changes in mitochondrial metabolite concentrations; therefore, we wanted to know whether the genes involved in these enzymatic activities were also affected in Rrm2b kiKO mice. We searched the public database MGI-Mouse Gene Expression Database (GXD) and identified 342 genes that are annotated as expressed in the renal cortex, as confirmed by RNA in situ, in situ reporter (knock-in), IHC, western blot, RT-PCR and/or northern blot analysis. The prediction scores of MitoProt, TargetP, MitoFates and MitoMiner were used as evidence of mitochondrial localization. Of the 342 genes, 67 encoded candidate mitochondrial proteins (Supplemental Table S2). We used the KEGG Pathway Mapping tool to illustrate the top 15 metabolic pathways that included the highest number of candidate mitochondrial proteins and differential abundant metabolites (Supplemental Table S3). Using mouse metabolic pathways (map mmu01100) as an overview, we observed a few pathways that had both the enzymes and the metabolic compounds highlighted, and some were in close proximity to each other in the pathway maps (Supplemental Fig. S4). Some essential metabolites and related enzymes showed significant changes in the Rrm2b deleted kidney. These metabolites and enzymes were involved in vital biological pathways, such as glycerolipid metabolism; glycine, serine and threonine metabolism; glycolysis; oxidative phosphorylation; the pentose phosphate pathway; and other amino acid metabolism pathways. We performed ELISA assays and confirmed that the glycerol concentration was elevated in the urine but not in the serum of Rrm2b kiKO mice compared with control mice (Fig. 4a). In Fig. 4b, we showed that the expression levels of aldehyde dehydrogenase family 7, member A1 (Aldh7a1), betaine-homocysteine methyltransferase 2 (Bhmt2), dimethylglycine dehydrogenase precursor (Dmgdh) and glycerol kinase (Gk) responsible for glycolysis, glycerolipid and amino acid metabolism were repressed. Interestingly, an increase in Bhmt expression caused the high levels of dimethylglycine (DMG) that were observed under Rrm2b deficiency conditions (Fig. 4b, Supplemental Table S1). In addition, some enzymes downstream of the abovementioned pathways, such as glucose-6-phosphate dehydrogenase X-linked (G6pdx); aldehyde dehydrogenase 18 family, member A1 (Aldh18a1, also known as P5cs, pyrroline 5 carboxylate synthase/Pyrroline 5 carboxylate dehydrogenase); and ornithine transcarbamylase (Otc), were elevated (Fig. 4b). There were also enzymes that showed no obvious expression differences between Rrm2b kiKO and F/F mice (Supplemental Fig. S5). Finally, the protein expression levels of P5cs and Pycr1 were similar to mRNA levels (Fig. 4c). All of these results indicate that Rrm2b deletion affects the mitochondrial metabolic activities the kidney.
Discussion
Rrm2b plays pivotal roles in nuclear genomic DNA repair and replication and repair of mitochondrial genomic DNA26. Additionally, Rrm2b has the capacity to scavenge ROS to protect against oxidative stress10. Rrm2b-deficient human and mouse models exhibit detectable decreases in the dNTP pool and DNA repair efficiency, resulting in severe damage to nuclear and mitochondrial DNA4,9. In addition, loss of Rrm2b led to declines in ROS scavenging and antioxidant capacity, damaged mitochondrial structures and exacerbated impairment of mitochondrial functions. All of these effects accelerated cellular oxidative stress in organisms (Fig. 5a).
In this study, we generated a renal tubular epithelial cell-specific Rrm2b knockout model and showed that Rrm2b deletion affected mitochondrial DNA integrity and metabolism, causing elevated oxidative damage. By combining metabolomics and experimental results, we illustrated the pathways influenced by Rrm2b deletion (Fig. 5b). Gk is a mitochondrial-bound enzyme that is abundantly expressed in the kidney and liver and catalyzes the formation of glycerol 3-phosphate from ATP and glycerol27. Our data indicated that reduced energy production resulting from defective mitochondrial respiration drives an elevation in the levels of glycerol 3-phosphate and glucose 6-phosphate, which trigger energy-producing pathways, such as oxidative phosphorylation and glycolysis. In addition, the pentose phosphate pathway can also be activated to produce more nucleotides for DNA repair. Aldh7a1 (also known as antiquitin) is found in the cytosol, nucleus, and mitochondria and is highly expressed in the kidney, liver and brain. Biochemically, Aldh7a1 catalyzes the conversion of D-glyceraldehyde to D-glycerate, which can enter the glycolysis pathway. Aldh7a1 can also metabolize betaine aldehyde to betaine to counteract hyperosmotic stress28,29. Additionally, Aldh7a1 can attenuate osmotic stress-induced apoptosis. However, Rrm2b deletion led to reduced Aldh7a1 expression and induced extreme oxidative stress and osmotic stress. Bhmt and Dmgdh are expressed in the proximal tubules of the renal cortex30,31. Aberrant expression of these two proteins under Rrm2b deficiency conditions caused DMG accumulation and decreases in L-homocysteine (Hcy) and serine levels, which consequently disrupted amino acid metabolism (Fig. 5b).
Increased Pycr and P5cs expression levels facilitate proline generation and indirectly enhance ROS generation while reducing TCA cycle flux32. Expression of both Pycr1 and P5cs were markedly increased by 8- and 4-fold respectively in Rrm2b kiKO mice compared with control (Rrm2b F/F), while the proline oxidase (Pox) that converts proline to P5C showed no obvious difference in expression. The up-regulation of proline biosynthesis genes can trigger the conversion of glutamine towards proline and oxidizing NAD(P)H to NAD(P) + molecules. The activation of Pycr1 and P5cs resulted from Rrm2b deletion maybe a compensatory mechanism that cells used to counteract the increasing production of ROS.
Phenotypes and related mechanisms
Based on our study, Rrm2b deletion in renal tubular cells caused several pathological defects in mice. Additionally, these defects were exacerbated with age, and some defects were similar to those observed in human disorders, as previously reported.
Changes in urine pH value
The proximal tubules regulate acid-base balance by secreting ammonia and reabsorbing filtrated bicarbonate. Urine biochemical analysis showed lower pH values in 6-month-old Rrm2b kiKO mice but not in younger mice; accordingly, we hypothesize that Rrm2b deletion may induce renal tubular acidemia type 2, also known as proximal renal tubular acidemia33,34. Human patients with this disease have a bicarbonate reabsorption defect in the kidney and intestine. Rrm2b deficiency in mice caused metabolic defects, functional loss of renal tubules, and maybe impaired bicarbonate reabsorption from urine in proximal tubular cells.
Mitochondrial defects mediate oxidative damage
The kidney is highly susceptible to ROS-induced damage. In addition, renal proximal tubular cells have abundant mitochondria and rely primarily on oxidative phosphorylation to obtain energy; thus, they are very sensitive to ROS-induced damage, such as mutation, apoptosis and mitochondrial-DNA-associated functional defects35. Although the effects of Rrm2b deficiency in the loop of Henle and collecting tubes are mostly unknown, oxidative damage mediated by mitochondria may lead to pathological changes in the loop of Henle and collecting tubes. Past studies have demonstrated that enhanced Rrm2b expression can reduce oxidative stress in both normal and oxidative-damage conditions6,12. Our data showed that Rrm2b deletion in renal tubular cells caused an increase in oxidative stress and a decrease in antioxidant capacity, which led to both morphological and functional mitochondrial defects. Additionally, exposure to oxidative stress can trigger increased expression of Pycr136,37, and indeed, we found enhanced expression of Pycr1 and Nrf2, another oxidative stress-induced gene, in our Rrm2b kiKO model. This suggests that Rrm2b deletion caused oxidative damage in the kidney. One of the critical functions of Pycr1 is to maintain mitochondrial function and integrity under oxidative damage conditions14,37. However, the compensatory effects of Pycr1 and other stress-induced genes were not sufficient to counteract and protect mitochondria against oxidative damage under Rrm2b deletion conditions. Furthermore, impaired antioxidant mechanisms and reduced ROS clearance can lead to oxidative damage and mitochondrial breakdown.
Impaired mitochondrial metabolism
Unbalanced metabolism usually induces an overload of metabolites, accompanied by accumulation of cellular damage and overall cellular stress. Aldh7a1 protects cells against osmotic stress and thus attenuates osmotic stress-induced oxidative stress by metabolizing toxic aldehydes to produce NAD(P)H, which helps restore the cellular redox balance29. Under Rrm2b-deficient conditions, a decrease in the Aldh7a1 expression level reduced carboxylic acid and betaine production, which indirectly intercepted pathways leading to oxidative stress and osmotic stress. In response to severe stress, compensatory mechanisms could be activated in the Rrm2b deleted kidney. One such mechanism is the proline generation and accumulation through the upregulation of P5cs and Pycr. Proline has also been reported to protect against oxidative stress, and its accumulation in cells is a response to physiological stress36.Another cellular compensation mechanism is enhanced Bhmt and reduced Dmgdh expression, both of which cause dimethylglycine accumulation and homocysteine consumption in the kidney, resulting in reduction of oxidative damage due to high levels of homocysteine. Previous reports have shown that homocysteine is a toxic compound to tissues in high concentrations38. Therefore, loss of Rrm2b in cells results in elevated oxidative stress and dysregulated metabolic activities, with subsequent activation of certain alternative compensatory pathways to counteract oxidative damage.
The importance of Rrm2b in kidney
Mitochondria supply ATP, which is required for critical cellular functions throughout the body, especially in highly energy-dependent organs. Kidneys require a large amount of energy to filter minerals and other materials, perform tubular reabsorption and pass urine out of the body. Renal proximal tubules have abundant mitochondria to support ion transfer, such as that performed by the Na+-K+ ATPase pump. This study indicated that Rrm2b not only mediates mitochondrial DNA replication and repair but is also critical for the maintenance of mitochondrial functional integrity and metabolic activities. Using an Rrm2b-deficient (Rrm2b kiKO) mouse model, we propose that Rrm2b is essential for normal functions of the kidney.
References
Tanaka, H. et al. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404, 42–49, https://doi.org/10.1038/35003506 (2000).
Lozano, G. & Elledge, S. J. p53 sends nucleotides to repair DNA. Nature 404, 24–25, https://doi.org/10.1038/35003670 (2000).
Nakano, K., Balint, E., Ashcroft, M. & Vousden, K. H. A ribonucleotide reductase gene is a transcriptional target of p53 and p73. Oncogene 19, 4283–4289 (2000).
Bourdon, A. et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 39, 776–780, https://doi.org/10.1038/ng2040 (2007).
Zhou, B. et al. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53. Cancer Res 63, 6583–6594 (2003).
Liu, X., Xue, L. & Yen, Y. Redox property of ribonucleotide reductase small subunit M2 and p53R2. Methods Mol Biol 477, 195–206, https://doi.org/10.1007/978-1-60327-517-0_15 (2008).
Xue, L. et al. Ribonucleotide reductase small subunit p53R2 facilitates p21 induction of G1 arrest under UV irradiation. Cancer Res 67, 16–21, https://doi.org/10.1158/0008-5472.CAN-06-3200 (2007).
Xue, L. et al. Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits. Cancer Res 63, 980–986 (2003).
Kimura, T. et al. Impaired function of p53R2 in Rrm2b-null mice causes severe renal failure through attenuation of dNTP pools. Nat Genet 34, 440–445, https://doi.org/10.1038/ng1212 (2003).
Xue, L. et al. Structurally dependent redox property of ribonucleotide reductase subunit p53R2. Cancer Res 66, 1900–1905, https://doi.org/10.1158/0008-5472.CAN-05-2656 (2006).
Wang, X. et al. Ribonucleotide reductase subunit p53R2 regulates mitochondria homeostasis and function in KB and PC-3 cancer cells. Biochem Biophys Res Commun 410, 102–107, https://doi.org/10.1016/j.bbrc.2011.05.114 (2011).
Kuo, M. L. et al. RRM2B suppresses activation of the oxidative stress pathway and is up-regulated by p53 during senescence. Sci Rep 2, 822, https://doi.org/10.1038/srep00822 (2012).
Kang, M. Y. et al. The critical role of catalase in prooxidant and antioxidant function of p53. Cell Death Differ 20, 117–129, https://doi.org/10.1038/cdd.2012.102 (2013).
Kuo, M. L. et al. PYCR1 and PYCR2 Interact and Collaborate with RRM2B to Protect Cells from Overt Oxidative Stress. Sci Rep 6, 18846, https://doi.org/10.1038/srep18846 (2016).
Shao, X., Somlo, S. & Igarashi, P. Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract. J Am Soc Nephrol 13, 1837–1846 (2002).
Shao, X., Johnson, J. E., Richardson, J. A., Hiesberger, T. & Igarashi, P. A minimal Ksp-cadherin promoter linked to a green fluorescent protein reporter gene exhibits tissue-specific expression in the developing kidney and genitourinary tract. J Am Soc Nephrol 13, 1824–1836 (2002).
Young, B., O’Dowd, G. & Woodford, P. 1 online resource (468 p (Churchill Livingston/Elsevier, Philadelphia, 2014).
Chen, Y. F. et al. Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice. Genes Dev 23, 1183–1194, https://doi.org/10.1101/gad.177950923/10/1183 (2009).
Park, J. Y. et al. p53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content. Circ Res 105, 705–712, 711 p following 712, https://doi.org/10.1161/CIRCRESAHA.109.205310 (2009).
Sato, Y. et al. Apobec2 deficiency causes mitochondrial defects and mitophagy in skeletal muscle. FASEB J, https://doi.org/10.1096/fj.201700493R (2017).
Fordahl, S. et al. Waterborne manganese exposure alters plasma, brain, and liver metabolites accompanied by changes in stereotypic behaviors. Neurotoxicol Teratol 34, 27–36, https://doi.org/10.1016/j.ntt.2011.10.003 (2012).
Pan, L. et al. An optimized procedure for metabonomic analysis of rat liver tissue using gas chromatography/time-of-flight mass spectrometry. J Pharm Biomed Anal 52, 589–596, https://doi.org/10.1016/j.jpba.2010.01.046 (2010).
Qiu, Y. et al. Urinary metabonomic study on colorectal cancer. J Proteome Res 9, 1627–1634, https://doi.org/10.1021/pr901081y (2010).
Qiu, Y. et al. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res 8, 4844–4850, https://doi.org/10.1021/pr9004162 (2009).
Jonsson, P. et al. High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. Anal Chem 77, 5635–5642, https://doi.org/10.1021/ac050601e (2005).
Thelander, L. Ribonucleotide reductase and mitochondrial DNA synthesis. Nat Genet 39, 703–704, https://doi.org/10.1038/ng0607-703 (2007).
Wirthensohn, G., Vandewalle, A. & Guder, W. G. Renal glycerol metabolism and the distribution of glycerol kinase in rabbit nephron. Biochem J 198, 543–549 (1981).
Sell, D. R., Strauch, C. M., Shen, W. & Monnier, V. M. 2-aminoadipic acid is a marker of protein carbonyl oxidation in the aging human skin: effects of diabetes, renal failure and sepsis. Biochem J 404, 269–277, https://doi.org/10.1042/BJ20061645 (2007).
Brocker, C. et al. Aldehyde dehydrogenase 7A1 (ALDH7A1) is a novel enzyme involved in cellular defense against hyperosmotic stress. J Biol Chem 285, 18452–18463, https://doi.org/10.1074/jbc.M109.077925 (2010).
Lang, H., Minaian, K., Freudenberg, N., Hoffmann, R. & Brandsch, R. Tissue specificity of rat mitochondrial dimethylglycine dehydrogenase expression. Biochem J 299(Pt 2), 393–398 (1994).
Delgado-Reyes, C. V., Wallig, M. A. & Garrow, T. A. Immunohistochemical detection of betaine-homocysteine S-methyltransferase in human, pig, and rat liver and kidney. Arch Biochem Biophys 393, 184–186, https://doi.org/10.1006/abbi.2001.2474 (2001).
Phang, J. M., Liu, W. & Zabirnyk, O. Proline metabolism and microenvironmental stress. Annu Rev Nutr 30, 441–463, https://doi.org/10.1146/annurev.nutr.012809.104638 (2010).
Haque, S. K., Ariceta, G. & Batlle, D. Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies. Nephrol Dial Transplant 27, 4273–4287, https://doi.org/10.1093/ndt/gfs493 (2012).
Rodriguez Soriano, J. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol 13, 2160–2170 (2002).
Percy, C. J., Power, D. & Gobe, G. C. Renal ageing: changes in the cellular mechanism of energy metabolism and oxidant handling. Nephrology (Carlton) 13, 147–152, https://doi.org/10.1111/j.1440-1797.2008.00924.x (2008).
Krishnan, N., Dickman, M. B. & Becker, D. F. Proline modulates the intracellular redox environment and protects mammalian cells against oxidative stress. Free Radic Biol Med 44, 671–681, https://doi.org/10.1016/j.freeradbiomed.2007.10.054 (2008).
Reversade, B. et al. Mutations in PYCR1 cause cutis laxa with progeroid features. Nat Genet 41, 1016–1021, https://doi.org/10.1038/ng.413 (2009).
Imbard, A. et al. High homocysteine induces betaine depletion. Biosci Rep 35, https://doi.org/10.1042/BSR20150094 (2015).
Acknowledgements
The authors acknowledge the technical support (sample preparation for transmission electron microscopy) provided by the TMU Core Facility. The authors also thank the Taiwan Animal Consortium (MOST 106-2319-B-001-004) – Taiwan Mouse Clinic, which is funded by the Ministry of Science and Technology (MOST) of Taiwan, for technical support in monitoring for metabolic cage and biochemical index analyses. This work was financially supported by the “TMU Research Center of Cancer Translational Medicine” from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan. This work was also supported by a Health and welfare surcharge of tobacco products grant (CECR grant: MOHW107-TDU-B-212-114014, MOHW108-TDU-B-212-124026 and MOHW108-TDU-B-212-124020 to Y.Y.). This work was supported by Ministry of Science and Technology (MOST-108-2321-B-038-003 to Y.Y.). This work was also supported by the Ministry of Science and Technology (grant number MOST105-2320-B-038-022-MY3 to Y.F.C.) and Taipei Medical University (Grant Numbers 105TMU-CIT-01-4 and 106TMU-CIT-01-4 to Y.F.C.).
Author information
Authors and Affiliations
Contributions
Y.F.C. designed the experiments, analyzed and interpreted the results, and wrote the manuscript. I.H.L. analyzed metabolomic data, performed functional profiling and drafted a portion of the manuscript. W.J.C. performed and analyzed the mouse models with kidney defects. Y.R.G. performed and analyzed the experiments related to molecular biology. M.S.W. designed and analyzed parts of the experiments. W.J. performed the metabolomic analysis. Y.Y. designed the experiments, analyzed the sequencing data and checked the final manuscript. All authors have read and approved the final version of this manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Chen, YF., Lin, IH., Guo, YR. et al. Rrm2b deletion causes mitochondrial metabolic defects in renal tubules. Sci Rep 9, 13238 (2019). https://doi.org/10.1038/s41598-019-49663-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-019-49663-3
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.